James Hart - Cardlytics VP People
| CDLX Stock | USD 3.93 0.13 3.42% |
Insider
James Hart is VP People of Cardlytics
| Address | 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308 |
| Phone | 888 792 5802 |
| Web | https://www.cardlytics.com |
Cardlytics Management Efficiency
The company has return on total asset (ROA) of (0.0762) % which means that it has lost $0.0762 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8612) %, meaning that it created substantial loss on money invested by shareholders. Cardlytics' management efficiency ratios could be used to measure how well Cardlytics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.6 in 2024. Return On Capital Employed is likely to drop to -0.35 in 2024. At this time, Cardlytics' Net Tangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to rise to 0.62 in 2024, whereas Total Assets are likely to drop slightly above 440 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Bryan Gildenberg | Omnicom Group | N/A | |
| William LaFoy | Boston Omaha Corp | 62 | |
| Brian Stevens | Advantage Solutions | 51 | |
| Joanne Trout | Omnicom Group | N/A | |
| Ashley Heller | QuinStreet | N/A | |
| Chip Zint | Deluxe | N/A | |
| John Roswech | Marchex | 55 | |
| Tim Braz | Innovid Corp | N/A | |
| Mitchell Gendel | Emerald Expositions Events | 54 | |
| Steven McGhie | Boston Omaha Corp | 57 | |
| Anthony Munk | Emerald Expositions Events | 59 | |
| Diarmuid Gill | Criteo Sa | N/A | |
| Julie Warner | Marchex | N/A | |
| Oleg Bershadsky | Integral Ad Science | 42 | |
| Niall Hogan | Integral Ad Science | N/A | |
| Yuval Pemper | Innovid Corp | 53 | |
| Todd Wilson | Marchex | N/A | |
| Manuela Montagnana | Criteo Sa | N/A | |
| Jonathan Chevalier | Cimpress NV | N/A | |
| Stephanie Geno | Innovid Corp | N/A | |
| Thomas Joseph | Integral Ad Science | N/A | |
Management Performance
| Return On Equity | -1.86 | ||||
| Return On Asset | -0.0762 |
Cardlytics Leadership Team
Elected by the shareholders, the Cardlytics' board of directors comprises two types of representatives: Cardlytics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardlytics. The board's role is to monitor Cardlytics' management team and ensure that shareholders' interests are well served. Cardlytics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardlytics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Evelyne Forester, Chief Officer | ||
| Carson Napps, Chief Officer | ||
| Jared Luskin, Senior Vice President for Growth Verticals | ||
| Jose Singer, Chief Officer | ||
| Alexis DeSieno, Chief Officer | ||
| Karim Temsamani, CEO Director | ||
| James Hart, VP People | ||
| Amit Gupta, CEO Director | ||
| Kirk Esq, Sec | ||
| Peter Davies, Head Operations | ||
| Nick Lynton, Chief Secretary | ||
| Craig Snodgrass, Chief Officer | ||
| Peter Chan, Chief Officer | ||
| Angie Amberg, Head Communications | ||
| Andrew Christiansen, Chief Officer |
Cardlytics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardlytics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.86 | ||||
| Return On Asset | -0.0762 | ||||
| Profit Margin | (0.94) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | 354.67 M | ||||
| Shares Outstanding | 50.82 M | ||||
| Shares Owned By Insiders | 5.13 % | ||||
| Shares Owned By Institutions | 61.57 % | ||||
| Number Of Shares Shorted | 7.1 M | ||||
| Price To Earning | (3.47) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.